Papillary carcinoma of the male breast in a comparatively young patient: A case report of a rare entity

,Dr Dolly Prashant,Dr Viplav Prashant

doi:10.17511/ijmrr.2020.i05.05

Abstract

Breast carcinoma in men is rare and intra-cystic papillary carcinoma of male breast is an extremelyrare entity. Papillary lesions of male breast comprise of the spectrum of lesions ranging from benignintraductal papilloma to intraductal papillary carcinoma and invasive papillary carcinoma. It occursmost commonly in the seventh decade of life and accounts for <1% of all breast malignancies. Thepresent case report is of a comparatively younger, 37 years old male who presented with a mass onlower quadrant (retro-areolar region) of the left breast.

Highlights

Breast masses include benign as well as malignant lesions and occur less frequently in male as compared to female
It has been observed that intra-cystic papillary carcinoma (IPC) in particular may present more often in men with gynecomastia [7,8]
The present study reports a case of intracystic papillary carcinoma of the breast in a 37 years old male patient

Summary

Introduction

Breast masses include benign as well as malignant lesions and occur less frequently in male as compared to female. The present study reports a case of intracystic papillary carcinoma of the breast in a 37 years old male patient. Mammography of the lesion revealed a large solid cystic mass lesion with predominant solid component measuring approximately 7.1 x 6.2 cm in size This mass showed significant internal vascularity, with suspicion of involvement of underlying musculature. Ultrasonography of the IPC lesion typically reveals a hypo-echoic area (which represents the cyst) with soft tissue echoes projecting from the wall of the cyst (intra-cystic tumour). The other etiological factors include obesity, cirrhosis, radiation exposure, drugs, head trauma (by increasing the prolactin production), local chest trauma, and smoking [1,2,3] Based on these findings, a final diagnosis of intracystic papillary carcinoma was made. The patient had received one cycle of chemotherapy but did not turn up for further follow-up

Findings

Discussion

Conclusion